Sunitinib
Links shared publicly online about this topic
Psychiatry Article | Sunitinib
mdlinx.com — “Psychotic symptoms in the course of sunitinib treatment for advanced renal cell cancer” View full resource at mdlinx.com
Most Recently Shared on November 15, 2010 at 1:15 pm By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Psychotic symptoms in the course of sunitinib treatment for advanced renal cell cancer: General Hospital Ps... http://bit.ly/cO1BTg #PSY
Oncology Medical News about Sunitinib
mdlinx.com — “Risk of Arterial Thromboembolic Events With Sunitinib and Sorafenib: A Systematic Review and Meta-Analysis of Clinical Trials” View full resource at mdlinx.com
Most Recently Shared on April 20, 2010 at 5:29 am By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Risk of Arterial Thromboembolic Events With Sunitinib and Sorafenib: A Systematic Review and Meta-Analysi... http://bit.ly/96BkkQ #oncology
Oncology Medical News about Sunitinib
mdlinx.com — “Sunitinib in combination with docetaxel in patients with advanced solid tumors: a phase I dose-escalation study” View full resource at mdlinx.com
Most Recently Shared on January 5, 2010 at 9:31 am By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Heme/Onc: Sunitinib in combination with docetaxel in patients with advanced solid tumors: a phase I dose-escalation stu http://url4.eu/13cNK
Papillary Renal Cell Carcinoma Unresponsive To Sunitinib
medicalnewstoday.com — “Of the more than 38,000 Americans diagnosed with renal cell carcinoma (RCC) each year, approximately 20 percent have non-clear cell forms of the disease. New findings shows that a non-clear cell f” View full resource at medicalnewstoday.com
Most Recently Shared on June 1, 2010 at 12:07 pm By:
Papillary Renal Cell Carcinoma Unresponsive To Sunitinib http://mnt.to/3Djg #cancer
Patients Treated With Sunitinib And Sorafenib Respond To Flu Vaccine
medicalnewstoday.com — “Patients treated with sunitinib and sorafenib responded to the flu vaccine, which suggests the agents do not damage the immune system as much as previously feared, according to a study in Clinical” View full resource at medicalnewstoday.com
Most Recently Shared on June 28, 2011 at 5:06 pm By:
MNT Colds / Flu News Health News
Patients Treated With Sunitinib And Sorafenib Respond To Flu Vaccine http://mnt.to/3XDN #flu
ingentaconnect Sunitinib: Various toxicities: case report
ingentaconnect.com — “ingentaconnect Sunitinib: Various toxicities: case report” View full resource at ingentaconnect.com
Most Recently Shared on March 7, 2011 at 5:49 am By:
Sunitinib: Various toxicities: case report: (Source: Reactions) http://bit.ly/g4y1Fy
Susan G. Komen for the Cure | Disappointing Results with Sunitinib
ww5.komen.org — “Susan G. Komen for the Cure | Disappointing Results with Sunitinib” View full resource at ww5.komen.org
Most Recently Shared on June 15, 2010 at 5:37 pm By:
Komen for the Cure Health Organization
#Komen #NEWS: Disappointing results with Sunitinib Inhibitor in women with HER2 negative breast #cancer. http://bit.ly/9GPcQ5
ODAC approves indication for sunitinib in treatment of PNET
endocrinetoday.com — “The FDA’s Oncologic Drugs Advisory committee voted 8-2 today in support of the use of Pfizer’s sunitinib in the treatment of unresectable” View full resource at endocrinetoday.com
Most Recently Shared on April 12, 2011 at 9:14 pm By:
#ODAC approves indication for #sunitinib in treatment of PNET http://bit.ly/i9bfOG
Patients treated with sunitinib and sorafenib respond to flu vaccine
eurekalert.org — “Patients treated with sunitinib and sorafenib responded to the flu vaccine, which suggests the agents do not damage the immune system as much as previously feared, according to a study in Clinical Cancer Research, a journal of the American Association for Cancer Research.” View full resource at eurekalert.org
Most Recently Shared on June 28, 2011 at 11:29 pm By:
Patients treated with sunitinib and sorafenib respond to flu vaccine: ( American Association for Cancer Research... http://bit.ly/kJHGSb
Susan G. Komen for the Cure | Disappointing Results with Sunitinib
ww5.komen.org — “Susan G. Komen for the Cure | Disappointing Results with Sunitinib” View full resource at ww5.komen.org
Most Recently Shared on August 4, 2010 at 5:05 pm By:
Komen for the Cure Health Organization
Results announced Fri say 2 random Suntinib trials didn't result in improvement for women w/ metastatic #breastcancer http://bit.ly/bckfhc
Pazopanib, Sunitinib and Other Recent Clinical Trials
onclive.com — “Pazopanib, Sunitinib and Other Recent Clinical Trials” View full resource at onclive.com
Most Recently Shared on April 19, 2011 at 5:49 pm By:
Ana M. Molina, MD Genitourinary Oncologist from @sloan_kettering Talks About Pazopanib and Other Recent Clinical Trials http://goo.gl/hVhEr
Sunitinib Benefit Explored in Poor-Prognosis Kidney Cancer
health.msn.com — “Sunitinib Benefit Explored in Poor-Prognosis Kidney Cancer” View full resource at health.msn.com
Most Recently Shared on July 16, 2009 at 1:36 pm By:
Sunitinib Benefit Explored in Poor-Prognosis Kidney Cancer http://bit.ly/Lg5qW
Hypertension as a Biomarker of Efficacy in Patients With Metastatic Renal Cell Carcinoma Treated With Sunitinib
jnci.oxfordjournals.org — “Hypertension as a Biomarker of Efficacy in Patients With Metastatic Renal Cell Carcinoma Treated With Sunitinib” View full resource at jnci.oxfordjournals.org
Most Recently Shared on May 5, 2011 at 2:00 am By:
Michael Fisch Physician, Doctor, Internist, Pain Medicine Physician, and Oncologist
Hypertension as biomarker for treatment efficacy? JNCI: sunitinib data in renal cell #cancer, http://ow.ly/4Nukp, #cardiac #heart
Threshold Pharmaceuticals Initiates Clinical Trial Evaluating TH-302 In Combination With Sunitinib
medicalnewstoday.com — “Threshold Pharmaceuticals, Inc. (Nasdaq: THLD), today announced the initiation of a Phase 1/2 dose escalation clinical trial of TH-302 in combination with sunitinib in patients with advanced renal” View full resource at medicalnewstoday.com
Most Recently Shared on June 30, 2011 at 4:05 pm By:
MNT Gastrointestinal Health News
Threshold Pharmaceuticals Initiates Clinical Trial Evaluating TH-302 In Combination With Sunitinib http://mnt.to/3XRy #gastrointestinal
News - Sunitinib Shows Promise in Patients With Advanced Renal Cancer, Poor Prognosis
docguide.com — “Sunitinib Shows Promise in Patients With Advanced Renal Cancer, Poor Prognosis” View full resource at docguide.com
Most Recently Shared on July 16, 2009 at 5:27 pm By:
Kidney Cancer Health Executive
Sunitinib Shows Promise in Patients With Advanced Renal Cancer, Poor Prognosis http://bit.ly/lppfD
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Related WisdomCards
Featuring the top 3 experts for this topic
-
Sandeep Pulim MD
Over 2K medical journal articles & health news summarized and delivered FREE to 35 specialties daily. Oncology, Rheumatology, Cardiology, Neurology, Psychiatry
-
Sandeep Pulim MD
Over 2K medical journal articles & health news summarized and delivered FREE to 35 specialties daily. Oncology, Rheumatology, Cardiology, Neurology, Psychiatry
-
Sandeep Pulim MD
Over 2K medical journal articles & health news summarized and delivered FREE to 35 specialties daily. Oncology, Rheumatology, Cardiology, Neurology, Psychiatry
Advertisement
